FSS icon
  • WHY FSS?
    • About Us
    • Careers
  • SERVICES
    • Data Management
    • Biostatistics
    • Quality
    • Monitoring
  • OUTREACH
    • Patient
    • STEM
    • Inclusivity and Sustainability
    • Community
  • RESOURCES
    • FSS News
    • Case Studies
    • Projects
    • Publications
  • CONTACT US
The HERA Trial: Adjuvant trastuzumab therapy reduces the risk of relapse across subgroups

The HERA Trial: Adjuvant trastuzumab therapy reduces the risk of relapse across subgroups

by Dewi Owens | Jun 1, 2008 | HERA, Publications

OVERVIEW An assessment of the magnitude of the clinical benefits of trastuzumab for subpopulations defined by nodal and steroid hormone receptor status using data from the Herceptin Adjuvant (HERA) study. TITLE OF PUBLICATION Estimating the magnitude of trastuzumab...
The HERA Trial: Results of the First Planned Interim Analysis

The HERA Trial: Results of the First Planned Interim Analysis

by Dewi Owens | Oct 20, 2005 | HERA, Publications

OVERVIEW The New England Journal of Medicine reports the results, at the first planned interim analysis (median follow-up of one year), only of treatment with trastuzumab for one year or observation.  The Herceptin Adjuvant (HERA) (Breast International Group [BIG]...
Next Entries »

Recent Posts

  • FLAIR | British Journal of Haematology
  • COLONIZE | Annals of Internal Medicine
  • APHINITY | European Journal of Cancer
  • Navigating the biopharma services landscape
  • ALEXANDRA | Journal of the American Medical Association (JAMA)

Recent Comments

No comments to show.


Data Protection

EU Representative

Privacy

Cookies

CONTACT US
LinkedIn Logo

Frontier Science (Scotland) Ltd © 2022
Scottish Charity: SCO33112 | Scottish Company: SC220936

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}